LOS ANGELES, CA and DUBAI, UNITED ARAB EMIRATES--(Marketwired - May 7, 2013) - MMRGlobal, Inc. (
In April 2011, MMRGlobal CEO Robert H. Lorsch met with His Highness Sheikh Hamad Bin Khalifa Al-Thani, the Emir of Qatar, to discuss offering its products and services in Qatar's Science & Technology Park, where a Middle Eastern PHR platform to cover the region could also be hosted. The Company has continued to make inroads in Qatar through these contacts and others in Australia. In support of this and the Company's many other efforts, Ararat International has numerous representatives throughout the Middle East, including Turkey, Kuwait, Saudi Arabia, Qatar, United Arab Emirates and the Kingdom of Bahrain. Because the Middle East is known to have one of the highest concentrations of expats in the world, billions of dollars are being spent to build Personal Health Record systems so that travelers and the expat community have their medical records wherever they are in an emergency.
According to Lorsch, "We have been working on identifying representation in the Middle East since 2011 when we were introduced to the Emir of Qatar. It is our plan to work with Ararat International to identify specialists in the region who can partner and support us. Since the beginning of last year, there has been an aggressive movement in the region to create eHealth products and services with particular emphasis on PHRs. Numerous multinational organizations and at least one government have asked us to consider participating in the region as a strategic partner in eHealth programs. However, regional protocols require that we need support in doing business in the region which is where Ararat International comes in. If we are investing in the market, we want to succeed in the market, and this is one way to help ensure our success."
Garo S. Vanian, President of Ararat International , who was awarded the French Legion of Honor in 1993 for the development of Franco-African Business Relations, said, "We look forward to representing MMRGlobal's health IT products and services in Ararat International's territories in the Middle East. This is a great opportunity because it enables businesses and organizations in this region to quickly implement the newest technologies in eHealth. By offering MyMedicalRecords, we can take advantage of trends and successes in the U.S. and apply it to the healthcare industry in the Middle East. We look forward to starting presentations with our largest business clients as soon as next week when our Los Angeles team is in Dubai."
About Ararat International Ararat International™ and Ararat, Inc., incorporated in Nevada, operating through its wholly-owned foreign subsidiary, Ararat International Trading LLC, is a limited liability company incorporated in Dubai, United Arab Emirates. The company was established in 1974 as sole distributors of consumer, defense, agricultural, and transportation products for the Middle Eastern and African Economies. Family-owned and operated, Ararat International is referred to by the Sunday Times™ UK AS "the Harrods™ of Khartoum" due to the big affiliations (or big brands) Ararat represents. To learn more about Ararat, Inc. go to www.araratinc.com .
About MMRGlobal MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro , is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com . View demos and video tutorials of the Company's products and services at www.mmrtheater.com .
Forward-Looking Statements All statements in this press release that are not strictly historical in nature, including, without limitation, the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, agents, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry both in the U.S. and internationally; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
CONTACT: Michael Selsman Public Communications Co. ms@publiccommunications.biz (310) 922-7033
